Patents by Inventor Daniel Gelbart

Daniel Gelbart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240125402
    Abstract: A throttle valve creates the equivalent of a small orifice by using a much larger orifice which is turned on and off periodically, creating a flow equivalent to a much smaller orifice. The ratio of on time to off time is changed to create the desired effective orifice. By using an elastomeric member to form the orifice seal, solid particles do not interfere with the operation of the valve.
    Type: Application
    Filed: October 15, 2022
    Publication date: April 18, 2024
    Inventor: Daniel Gelbart
  • Patent number: 11801091
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: October 31, 2023
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Patent number: 11751940
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: September 12, 2023
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Publication number: 20230158319
    Abstract: The present technology may be applied to selectively heat one or more diseased areas in the lung while limiting heating to the healthy area and surrounding tissue. This heating provides a therapeutic effect. The selective heating of diseased tissues may be achieved by exposing the lung to an electromagnetic field to cause dielectric or eddy current heating. The present technology is particularly useful for treating emphysema as the diseased areas in emphysema patients have reduced blood flow. The diseased areas will heat up rapidly while the healthy tissue will be cooled by blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. In one described embodiment the frequency of the electromagnetic radiation is selected to satisfy certain resonance conditions of the apparatus.
    Type: Application
    Filed: November 25, 2022
    Publication date: May 25, 2023
    Inventors: Kar-Pan WONG, Eran ELIZUR, Evan GOODACRE, Susanna Kim WOLFF, Daniel GELBART
  • Patent number: 11633231
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: April 25, 2023
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Publication number: 20220400953
    Abstract: The invention may be applied to selectively heat a diseased area in the lung while minimizing heating to the healthy area and surrounding tissue. This can be done by exposing the lung to an electromagnetic field causing dielectric or eddy current heating. The invention is particularly useful for treating emphysema as the diseased areas in emphysema patients have reduced blood flow. The diseased area will heat up rapidly while the healthy tissue will be cooled by the blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. To avoid heating of surrounding organs the direction of the electromagnetic energy may be switched in a way it always passes through lungs but only intermittently passes through adjacent organs.
    Type: Application
    Filed: August 23, 2022
    Publication date: December 22, 2022
    Inventors: Samuel Victor LICHTENSTEIN, Daniel GELBART, Eran ELIZUR, Kevin James CANNONS
  • Patent number: 11445911
    Abstract: The invention may be applied to selectively heat a diseased area in the lung while minimizing heating to the healthy area and surrounding tissue. This can be done by exposing the lung to an electromagnetic field causing dielectric or eddy current heating. The invention is particularly useful for treating emphysema as the diseased areas in emphysema patients have reduced blood flow. The diseased area will heat up rapidly while the healthy tissue will be cooled by the blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. To avoid heating of surrounding organs the direction of the electromagnetic energy may be switched in a way it always passes through lungs but only intermittently passes through adjacent organs.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: September 20, 2022
    Assignee: Ikomed Technologies Inc.
    Inventors: Samuel Victor Lichtenstein, Daniel Gelbart, Eran Elizur, Kevin James Cannons
  • Patent number: 11432874
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: September 6, 2022
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Publication number: 20220260314
    Abstract: The invention uses a furnace retort made of silicon carbide to create a sintering furnace having no cold areas during debinding while having low heat losses during sintering. This is achieved by varying the wall thickness of the retort and taking advantage of the large increase in thermal conductivity of silicon carbide at lower temperatures. The special properties of silicon carbide also allow rapid cooling by exposing the outside of the retort directly to a high flow of cooling air.
    Type: Application
    Filed: October 6, 2021
    Publication date: August 18, 2022
    Inventors: Daniel Gelbart, Thomas Robert Curran
  • Patent number: 11413091
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: August 16, 2022
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Patent number: 11399890
    Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: August 2, 2022
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Samuel Victor Lichtenstein
  • Patent number: 11389232
    Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: July 19, 2022
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Samuel Victor Lichtenstein
  • Patent number: 11389231
    Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: July 19, 2022
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Samuel Victor Lichtenstein
  • Patent number: 11331141
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: May 17, 2022
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Publication number: 20220142706
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Application
    Filed: January 26, 2022
    Publication date: May 12, 2022
    Inventors: Daniel GELBART, Douglas Wayne GOERTZEN, Fernando Luis de Souza LOPES
  • Patent number: 11304751
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: April 19, 2022
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Publication number: 20220047328
    Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.
    Type: Application
    Filed: October 28, 2021
    Publication date: February 17, 2022
    Inventors: Daniel GELBART, Samuel Victor LICHTENSTEIN
  • Publication number: 20220031391
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Application
    Filed: October 13, 2021
    Publication date: February 3, 2022
    Inventors: Daniel GELBART, Douglas Wayne GOERTZEN, Fernando Luis de Souza LOPES
  • Patent number: 11076913
    Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: August 3, 2021
    Assignee: KARDIUM INC.
    Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
  • Patent number: 11033392
    Abstract: An elastic structure is introduced percutaneously into the left ventricle and attached to the walls of the ventricle. Over time the structure bonds firmly to the walls via scar tissue formation. The structure helps the ventricle expand and fill with blood during the diastolic period while having little affect on systolic performance. The structure also strengthens the ventricular walls and limits the effects of congestive heart failure, as the maximum expansion of the support structure is limited by flexible or elastic members.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: June 15, 2021
    Assignee: KARDIUM INC.
    Inventors: Samuel Victor Lichtenstein, Daniel Gelbart, William Gelbart